Deryugina Elena I, Quigley James P
The Scripps Research Institute, La Jolla, CA, USA.
Biochim Biophys Acta. 2010 Jan;1803(1):103-20. doi: 10.1016/j.bbamcr.2009.09.017. Epub 2009 Oct 2.
A number of extensive reviews are available discussing the roles of MMPs in various aspects of cancer progression from benign tumor formation to overt cancer present with deadly metastases. This review will focus specifically on the evidence functionally linking the MMPs and tumor-induced angiogenesis in various in vivo models. Emphasis has been placed on the cellular origin of the MMPs in tumor tissue, the requirement of proMMP activation and the resulting proteolytic activity for the induction and progression of tumor angiogenesis, and the pleiotropic roles for some of the MMPs. The functional mechanisms of the angiogenic MMPs are discussed as well as their catalytic detection in complex biological systems. In addition, the contribution of active MMPs to metastatic spread and establishment of secondary metastasis will be discussed in view of the findings indicating that MMPs are involved in the preparation of pre-metastatic niches. Finally, the most recent evidence, indicating the pro-metastatic consequences of anti-angiogenic therapies employing MMP inhibitors will be presented as examples highlighting possible outcomes of interfering with the pleiotropic nature of the MMP functionality.
已有多篇全面综述探讨了基质金属蛋白酶(MMPs)在癌症进展各个方面的作用,从良性肿瘤形成到伴有致命转移的明显癌症。本综述将特别关注在各种体内模型中,将MMPs与肿瘤诱导的血管生成在功能上联系起来的证据。重点在于肿瘤组织中MMPs的细胞来源、前MMP激活的必要性以及由此产生的蛋白水解活性对肿瘤血管生成诱导和进展的作用,以及某些MMPs的多效性作用。讨论了血管生成性MMPs的功能机制及其在复杂生物系统中的催化检测。此外,鉴于有研究表明MMPs参与了前转移微环境的形成,将讨论活性MMPs对转移扩散和继发性转移形成的作用。最后,将展示最新证据,即使用MMP抑制剂的抗血管生成疗法的促转移后果,以此为例突出干扰MMP功能多效性可能产生的结果。